FETOMATERNAL OUTCOME IN PREGNANCIES COMPLICATED BY POLYCYSTIC OVARY SYNDROME: A PROSPECTIVE COHORT STUDY
Main Article Content
Keywords
Polycystic Ovary Syndrome, Pregnancy Outcomes, Gestational Diabetes, Preeclampsia, Fetal Growth
Abstract
Polycystic Ovary Syndrome (PCOS) is among the most common endocrine disorders in reproductive-age women, and its association with high‑risk pregnancy has been increasingly recognized. Evidence regarding its effects on fetomaternal outcomes is still mixed and applies to South Asian populations as well.
Aims and Objectives: This paper, therefore, seeks to assess and compare Maternal and Neonatal Outcomes among Pregnant women with PCOS as compared to those without PCOS.
Materials and methods: This prospective cohort study was conducted in the Department of Obstetrics and Gynecology between January 2022 and June 2024 at a Tertiary Care Hospital in North India. Overall, 160 pregnant women with a single fetus were recruited, including the PCOS group of 71 women diagnosed by Rotterdam criteria and non‑PCOS controls (n =79) matched for baseline characteristics. Maternal (BMI, Miscarriage, Gestational Diabetes Mellitus, Gestational Hypertension, Preeclampsia, Mode of Delivery) and Neonatal Outcomes (Gestational age at birth, Weight at birth, Intrauterine Growth restriction rate, Amniotic fluid Abnormalities, and Admission to the NICU) were examined.
Results: The findings of this study confirm that pregnancies complicated by PCOS are associated with increased Maternal and Neonatal morbidity.
Conclusion: This study underscores the need for intensified antenatal surveillance and tailored management strategies in women with PCOS.
References
2. Barber, T. M., McCarthy, M. I., Wass, J. A. H., & Franks, S. (2006). Obesity and polycystic ovary syndrome. Clinical Endocrinology, 65(2), 137–145.
3. Boomsma, C. M., Eijkemans, M. J. C., Hughes, E. G., Visser, G. H. A., Fauser, B. C. J. M., & Macklon, N. S. (2006). A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Human Reproduction Update, 12(6), 673–683.
4. Dehghani Firoozabadi, A., Dehghani Firouzabadi, R., Eftekhar, M., Sadat Tabatabaei Bafghi, A., & Shamsi, F. (2020). Maternal and neonatal outcomes among pregnant women with different polycystic ovary syndrome phenotypes: A cross-sectional study. International Journal of Reproductive BioMedicine, 18(5), 339–346. https://doi.org/10.18502/ijrm.v13i5.7154
5. Doherty, D. A., Newnham, J. P., Bower, C., & Hart, R. (2015). Implications of polycystic ovary syndrome for pregnancy and for the health of offspring. Obstetrics & Gynecology, 125(6), 1397–1406.
6. Han, A. R., Kim, H. O., Cha, S. W., Park, C. W., Kim, J. Y., & Yang, K. M. (2011). Adverse pregnancy outcomes with assisted reproductive technology in patients with polycystic ovary syndrome. Human Reproduction, 26(9), 2335–2343.
7. Kjerulff, L. E., Sanchez-Ramos, L., & Duffy, D. (2011). Pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis. American Journal of Obstetrics and Gynecology, 204(6), 558.e1–558.e6.
8. Kollmann, M., Klaritsch, P., Martins, W. P., Guenther, F., Schneider, V., Herzog, S. A., Craciunas, L., Lang, U., Obermayer-Pietsch, B., Lerchbaum, E., & Raine-Fenning, N. (2015). Maternal and neonatal outcomes in pregnant women with PCOS: Comparison of different diagnostic definitions. Human Reproduction, 30(10), 2396–2403. https://doi.org/10.1093/humrep/dev187
9. Legro, R. S., et al. (2009). Risk factors for gestational diabetes mellitus in women with polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism, 94(5), 1650–1656.
10. Ma, Y., Cai, J., Liu, L. W., Wen, T., Huang, W., Hou, W., Wei, Z., Xu, Y., Xu, Y., Wang, Y., & Mai, Q. (2024). Causal relationships exist between polycystic ovary syndrome and adverse pregnancy and perinatal outcomes: A Mendelian randomization study. Frontiers in Endocrinology, 15, 1327849. https://doi.org/10.3389/fendo.2024.1327849
11. March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010). The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction, 25(2), 544–551.
12. Paradisi, G., et al. (2009). Metformin reduces the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome. Fertility and Sterility, 91(1), 114–119.
13. Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population-based cohort study. BMJ. 2011 Oct 13;343:d6309. doi: 10.1136/bmj.d6309
14. Wang, E. T., Calderon-Margalit, R., Cedars, M. I., Daviglus, M. L., Merkin, S. S., Schreiner, P. J., Sternfeld, B., Wellons, M., Schwartz, S. M., Lewis, C. E., Williams, O. D., Siscovick, D. S., & Bibbins-Domingo, K. (2011). Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia. Obstetrics & Gynecology, 117(1), 6–13. https://doi.org/10.1097/AOG.0b013e31820209bb
15. Wartena, R., & Matjila, M. (2023). Polycystic ovary syndrome and recurrent pregnancy loss: A review of literature. Frontiers in Endocrinology, 14, 1183060. https://doi.org/10.3389/fendo.2023.1183060
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Iflah Akbar
Senior Resident (MD/MS), Department of Obstetrics and Gynecology, SKIMS Srinagar, J&K, India. Corresponding Author: E-mail: [email protected]
Saima Yousuf Wani
Senior Resident (MD/MS), Department of Obstetrics and Gynecology, Government Medical College Srinagar, J&K, India.
Rabia Khurshid Sirwal
Professor, Department of Obstetrics and Gynecology, SKIMS Srinagar, J&K, India.
Imran Mansoor Shah
Medical Officer, Department of Health and Medical Education, Jammu and Kashmir, India.
